Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newcastle Disease Virus (NDV)”

7 trials

Showing 7 of 7 results

Testing effectiveness (Phase 2)WithdrawnNCT00348842
What this trial is testing

Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-cancer Modalities

Who this might be right for
Metastatic CancerNewcastle Disease Virus (NDV)
Hadassah Medical Organization
Testing effectiveness (Phase 2)Looking for participantsNCT07215520
What this trial is testing

Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults

Who this might be right for
COVID-19
CastleVax Inc. 200
Early research (Phase 1)Study completedNCT05181709
What this trial is testing

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

Who this might be right for
SARS-CoV-2
Sean Liu 35
Early research (Phase 1)Ended earlyNCT04613492
What this trial is testing

MEDI9253 in Combination With Durvalumab in Select Solid Tumors

Who this might be right for
Solid Tumors
AstraZeneca 40
Early research (Phase 1)Study completedNCT04871737
What this trial is testing

Study of a Live rNDV Based Vaccine Against COVID-19

Who this might be right for
SARS-CoV-2 Infection
Laboratorio Avi-Mex, S.A. de C.V. 91
Testing effectiveness (Phase 2)Study completedNCT05205746
What this trial is testing

Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence

Who this might be right for
SARS CoV 2 Infection
Laboratorio Avi-Mex, S.A. de C.V. 158
Large-scale testing (Phase 3)Study completedNCT05710783
What this trial is testing

Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

Who this might be right for
SARS-CoV-2 Infection
Laboratorio Avi-Mex, S.A. de C.V. 4,065

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation